ArticleAnnals of human genetics2008
Optimal two-stage design for case-control association analysis incorporating genotyping errors.
Article in Annals of human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Impact of genotypic errors with equal and unequal family contribution on accuracy of genomic prediction in aquaculture using simulation.Scientific reports · 2021Article
- Interleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2016Observational
- Identifying Potential Regions of Copy Number Variation for Bipolar Disorder.Microarrays (Basel, Switzerland) · 2014Article
- The efficacy of detecting variants with small effects on the Affymetrix 6.0 platform using pooled DNA.Human genetics · 2011Article
- Design of association studies with pooled or un-pooled next-generation sequencing data.Genetic epidemiology · 2010Article
- Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population.BMC medical genetics · 2009Article
- The cost effectiveness of duplicate genotyping for testing genetic association.Annals of human genetics · 2009Article
- Optimal 2-stage design with given power in association studies.Biostatistics (Oxford, England) · 2009Article
- Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.The pharmacogenomics journal · 2009Review
- Incorporating duplicate genotype data into linear trend tests of genetic association: methods and cost-effectiveness.Statistical applications in genetics and molecular biology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Two-stage design is a cost effective approach for identifying disease genes in genetic studies and it has received much attention recently. In general, there are two types of two-stage designs that differ on the methods and samples used to measure allele frequencies in the first stage: (1) Individual genotyping is used in the first stage; (2) DNA pooling is used in the first stage. In this paper, we focus on the latter. Zuo et al. (2006) investigated statistical power of such a design, among other things, but the cost of the study was not taken into account. The purpose of this paper is to study the optimal design under the given overall cost. We investigate how to allocate the resources to the two stages. Note that in addition to the measurement errors associated with DNA pooling, genotyping errors are also unavoidable with individual genotyping. Therefore, we discuss the optimal design combining genotyping errors associated with individual genotyping. The joint statistical distributions of test statistics in the first and second stages are derived. For a fixed cost, our results show that the optimal design requires no additional samples in the second stage but only that the samples in the first stage be re-used. When the second stage uses an entirely independent sample, however, the optimal design under a given cost depends on the population allele frequency and allele frequency difference between the case and control groups. For the current genotyping costs, we can roughly allocate 1/3 to 1/2 of the total sample size to the first stage for screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.